Michel Gowhari

1.1k total citations
31 papers, 488 citations indexed

About

Michel Gowhari is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michel Gowhari has authored 31 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 18 papers in Hematology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michel Gowhari's work include Hemoglobinopathies and Related Disorders (28 papers), Iron Metabolism and Disorders (12 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Michel Gowhari is often cited by papers focused on Hemoglobinopathies and Related Disorders (28 papers), Iron Metabolism and Disorders (12 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Michel Gowhari collaborates with scholars based in United States, Russia and Iran. Michel Gowhari's co-authors include Victor R. Gordeuk, Robert E. Molokie, Santosh L. Saraf, Xu Zhang, Johara Hassan, Jin Han, Roberto F. Machado, Damiano Rondelli, Pritesh Patel and Karen Sweiss and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Michel Gowhari

28 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Gowhari United States 13 397 293 164 58 51 31 488
Abdolreza Afrasiabi Iran 11 270 0.7× 306 1.0× 101 0.6× 15 0.3× 21 0.4× 20 458
Maria Marsella Italy 12 299 0.8× 283 1.0× 52 0.3× 42 0.7× 25 0.5× 30 473
Mahmut Yeral Türkiye 10 172 0.4× 164 0.6× 81 0.5× 52 0.9× 27 0.5× 49 318
Laurent Holvoet France 10 149 0.4× 110 0.4× 47 0.3× 29 0.5× 7 0.1× 29 296
Ranjeet Grover United States 10 600 1.5× 502 1.7× 254 1.5× 29 0.5× 26 0.5× 17 674
Irene T.M. Lindenburg Netherlands 14 179 0.5× 493 1.7× 455 2.8× 239 4.1× 20 0.4× 20 704
Mohammad I El-Mouzan Saudi Arabia 9 130 0.3× 111 0.4× 70 0.4× 22 0.4× 29 0.6× 11 422
M. Forbes Jamaica 8 311 0.8× 246 0.8× 129 0.8× 15 0.3× 16 0.3× 10 373
Catherine Stroud United Kingdom 11 76 0.2× 97 0.3× 68 0.4× 95 1.6× 13 0.3× 25 326
Paula K. Groncy United States 9 105 0.3× 130 0.4× 96 0.6× 28 0.5× 17 0.3× 14 360

Countries citing papers authored by Michel Gowhari

Since Specialization
Citations

This map shows the geographic impact of Michel Gowhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Gowhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Gowhari more than expected).

Fields of papers citing papers by Michel Gowhari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Gowhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Gowhari. The network helps show where Michel Gowhari may publish in the future.

Co-authorship network of co-authors of Michel Gowhari

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Gowhari. A scholar is included among the top collaborators of Michel Gowhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Gowhari. Michel Gowhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Jin, Christopher Holden, Robert E. Molokie, et al.. (2020). Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. British Journal of Haematology. 191(3). e70–e72. 4 indexed citations
2.
Saraf, Santosh L., Pritesh Patel, Karen Sweiss, et al.. (2020). Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease. PLoS ONE. 15(2). e0229710–e0229710. 13 indexed citations
3.
Khan, Mahir, Andrew Srisuwananukorn, Santosh L. Saraf, et al.. (2020). Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease. Blood. 136(Supplement 1). 24–25.
4.
Zhang, Xu, Jin Han, Chika Nwachukwu, et al.. (2020). Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center. Blood. 136(Supplement 1). 22–23. 3 indexed citations
5.
Han, Jin, Xu Zhang, Santosh L. Saraf, et al.. (2018). Risk factors for vitamin D deficiency in sickle cell disease. British Journal of Haematology. 181(6). 828–835. 18 indexed citations
6.
Saraf, Santosh L., Annie Oh, Pritesh Patel, et al.. (2018). Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 24(8). 1759–1765. 43 indexed citations
7.
Jain, Shivi, Andrew Srisuwananukorn, Santosh L. Saraf, et al.. (2018). Cancer Incidence in Sickle Cell Disease:an Institutional Experience. Blood. 132(Supplement 1). 1087–1087.
8.
9.
Molokie, Robert E., Michel Gowhari, Yingwei Yao, et al.. (2017). Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit. The American Journal of Emergency Medicine. 36(1). 88–92. 23 indexed citations
10.
Field, Joshua J., Elaine M. Majerus, Victor R. Gordeuk, et al.. (2017). Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Advances. 1(20). 1645–1649. 37 indexed citations
11.
Han, Jin, Santosh L. Saraf, Xu Zhang, et al.. (2016). Patterns of opioid use in sickle cell disease. American Journal of Hematology. 91(11). 1102–1106. 29 indexed citations
12.
Molokie, Robert E., Donald Lavelle, Michel Gowhari, et al.. (2016). Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic Epigenetic Disease Modification for Sickle Cell Disease. Blood. 128(22). 124–124. 2 indexed citations
13.
Choi, Jun Hyuk, Jin Han, Michel Gowhari, et al.. (2016). Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease. Blood. 128(22). 3666–3666. 1 indexed citations
14.
Zhang, Xu, Wei Zhang, Santosh L. Saraf, et al.. (2015). Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease. Human Genetics. 134(8). 895–904. 13 indexed citations
15.
Saraf, Santosh L., Annie Oh, Pritesh Patel, et al.. (2015). Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 22(3). 441–448. 99 indexed citations
16.
Han, Jin, Santosh L. Saraf, Xu Zhang, et al.. (2015). Chronic Opioid Use Pattern in Adult Patients with Sickle Cell Disease. Blood. 126(23). 3400–3400. 3 indexed citations
17.
Saraf, Santosh L., Xu Zhang, Tamir Kanias, et al.. (2013). Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. British Journal of Haematology. 164(5). 729–739. 82 indexed citations
18.
Saraf, Santosh L., Mohammed Farooqui, Michel Gowhari, et al.. (2011). Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease. British Journal of Haematology. 153(3). 386–392. 5 indexed citations
19.
Oryan, Ahmad, et al.. (2009). Prevalence of Cryptosporidium infection in camels (Camelus dromedarius) in a slaughterhouse in Iran.. PubMed. 26(3). 267–73. 21 indexed citations
20.
Ciurea, Stefan O., Keith R. Thulborn, & Michel Gowhari. (2006). Dural venous sinus thrombosis in a patient with sickle cell disease: Case report and literature review1. American Journal of Hematology. 81(4). 290–293. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdolreza Afrasiabi Breakdown of academic impact, for papers by Maria Marsella Breakdown of academic impact, for papers by Mahmut Yeral Breakdown of academic impact, for papers by Laurent Holvoet Breakdown of academic impact, for papers by Ranjeet Grover Breakdown of academic impact, for papers by Irene T.M. Lindenburg Breakdown of academic impact, for papers by Mohammad I El-Mouzan Breakdown of academic impact, for papers by M. Forbes Breakdown of academic impact, for papers by Catherine Stroud Breakdown of academic impact, for papers by Paula K. Groncy
Rankless by CCL
2026